A BRISTOL BASED PHARMACEUTICAL COMPANY IS ATTEMPTING TO PURCHASE ANOTHER BUSINESS. KING PHARMACEUTICALS HAS OFFERED ALPHARMA INCORPORATED, 1.4 BILLION DOLLARS IN CASH AS PART OF AN UNSOLICITED BUYOUT OFFER. THAT EQUATES TO 33 DOLLARS A SHARE. THE OFFER WAS MADE ON AUGUST 4TH AND NO ACTION HAS TAKEN PLACE YET. KING WANTS TO CREATE A LARGE DIVERSE SPECIALTY PHARMACEUTICAL COMPANY AND EXPAND ITS PAIN THERAPY PRODUCTS.